Clinical Trial Update: Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of lapaquistat acetate on blood cholesterol levels in subjects with dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED